Skip to Main

Bernd Ziegler leads The Boston Consulting Group’s Health Care practice in Central Europe, Middle East, and Africa. He also leads the firm’s construction and real estate topics in Germany and is a member of BCG’s Marketing & Sales practice.

Since joining BCG in 1999, Bernd has worked extensively with clients in the pharmaceutical industry, with a strong focus on issues related to corporate strategy. He also has particular experience in marketing and sales, research and development, channel strategy, and commercial efficiency in biopharma.

In the course of his career, Bernd has developed strategic plans, growth strategies, and market-entry strategies for a number of biopharma companies. He has deep experience in postmerger integrations in a variety of sectors.

Before joining BCG, Bernd was involved in scientific work at the Max Planck Institute for Medical Research in Heidelberg.

AREAS OF EXPERTISE

EDUCATION

  • PhD, Max Planck Institute for Medical Research
  • MSc, chemistry, University of Stuttgart and University of Cincinnati

Publications and Videos

" "

For Pharmaceutical Companies, Three Steps to Value with Generative AI

New GenAI offerings can benefit virtually every aspect of an organization, boosting efficiency and productivity in areas ranging from R&D to commercial activities.
COVID-19 Opens a New Era for Real-World Evidence in Pharma-rectangle.jpg

COVID-19 Opens a New Era for Real-World Evidence in Pharma

To capture the opportunities, companies must build a fit-for-purpose strategy while proactively helping to shape the regulatory environment.
women-in-digital-2880x1620-tcm9-208115.jpg

Winning the Race for Women in Digital

To build the digital workforce that the future demands, companies must recruit—and retain—women.
gauging-longterm-impact-in-social-sector-1694x950-tcm9-63401.jpg

Gauging Long-Term Impact in the Social Sector

Few large international nongovernmental organizations have a good way to measure long-term impact in the social sector. Here’s an effective approach that one organization has developed.